[PDF][PDF] Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the …
P Bader, H Kreyenberg, GHR Henze… - Journal of Clinical …, 2009 - researchgate.net
Purpose Minimal residual disease (MRD) before allogeneic stem-cell transplantation was
shown to predict outcome in children with relapsed acute lymphoblastic leukemia (ALL) in …
shown to predict outcome in children with relapsed acute lymphoblastic leukemia (ALL) in …
Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia …
P Bader, H Kreyenberg, GHR Henze, C Eckert… - Journal of Clinical …, 2009 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Minimal residual disease (MRD)
before allogeneic stem-cell transplantation was shown to predict outcome in children with …
before allogeneic stem-cell transplantation was shown to predict outcome in children with …
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL …
P Bader, H Kreyenberg, GHR Henze… - Journal of clinical …, 2009 - pubmed.ncbi.nlm.nih.gov
Purpose Minimal residual disease (MRD) before allogeneic stem-cell transplantation was
shown to predict outcome in children with relapsed acute lymphoblastic leukemia (ALL) in …
shown to predict outcome in children with relapsed acute lymphoblastic leukemia (ALL) in …
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL …
P Bader, H Kreyenberg, GH Henze… - Journal of Clinical …, 2008 - europepmc.org
Purpose Minimal residual disease (MRD) before allogeneic stem-cell transplantation was
shown to predict outcome in children with relapsed acute lymphoblastic leukemia (ALL) in …
shown to predict outcome in children with relapsed acute lymphoblastic leukemia (ALL) in …
[PDF][PDF] Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic …
P Bader, H Kreyenberg, GHR Henze, C Eckert… - J Clin Oncol, 2008 - academia.edu
Purpose Minimal residual disease (MRD) before allogeneic stem-cell transplantation was
shown to predict outcome in children with relapsed acute lymphoblastic leukemia (ALL) in …
shown to predict outcome in children with relapsed acute lymphoblastic leukemia (ALL) in …
Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia …
P Bader, H Kreyenberg, GHR Henze… - Journal of Clinical …, 2009 - ascopubs.org
Purpose Minimal residual disease (MRD) before allogeneic stem-cell transplantation was
shown to predict outcome in children with relapsed acute lymphoblastic leukemia (ALL) in …
shown to predict outcome in children with relapsed acute lymphoblastic leukemia (ALL) in …
[引用][C] Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic …
P BADER, H KREYENBERG… - Journal of clinical …, 2009 - pascal-francis.inist.fr
Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell
Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia : The ALL-REZ …
Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia : The ALL-REZ …
[引用][C] Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the …
P BADER - J clin Oncol., 2009 - cir.nii.ac.jp
Prognostic value of minimal residual disease quantification before allogeneic stem-cell
transplantation in relapsed childhood acute lymphoblastic leukemia : the ALL-REZ BFM Study …
transplantation in relapsed childhood acute lymphoblastic leukemia : the ALL-REZ BFM Study …